NBC News @NBCNews
Heart disease patients using the common antibiotic clarithromycin, sold under the brand name Biaxin, have an increased risk of heart problems or death that can occur years later, the Food and Drug Administration said. https://t.co/QE4N3GwhUP — PolitiTweet.org